Clinical Trials Browser

Phase 3 × relatlimab × Clear all

NCT05002569 2026-01-08

RELATIVITY-098

Phase 3 Terminated

1,093 enrolled 15 charts

Melanoma

NCT05625399 2025-08-24

RELATIVITY-127

Phase 3 Active not recruiting

Melanoma